mrcgp akt MCQ (SBA): Rheumatoid arthritis disease-modifying therapy

Instant feedback + full explanation. One question, done properly.

EasyRheumatologyRheumatoid arthritis disease-modifying therapymrcgp aktmrcp part 1ukmlaprescribing safety assessment

A 48-year-old woman starting methotrexate for rheumatoid arthritis asks about co-prescribed medication to reduce adverse effects. What should be added?

Educational content. Not a substitute for clinical judgement or local policy.

mrcgp akt MCQ: Rheumatoid arthritis disease-modifying therapy — Answer